Provides Protection Through Sept. 2044; Will Be Listed in FDA’s Orange Book CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical ...

Shares of Nuwellis are skyrocketing Wednesday morning. The medical technology company announced it has secured a key U.S.

Polypave court shield is a patented crack prevention product for tennis courts and pickleball courts This achievement marks a major milesto ...

After being a regular presence in their living rooms, All Elite Wrestling seems to be heading to fans' kitchens.

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension This patent covers novel cyclic peptides and their use in treating solid ...

Madrigal Pharmaceuticals shares rose after the biopharmaceutical company received a U.S. patent for its Rezdiffra treatment. Shares were up 11% at $345.24 Wednesday. The stock has been up 12.8% this ...

Second on the list of most trademark applications in fiscal 2024, which ended Sept. 30, was Games Global USA Inc., one of 10 ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, ...

“Expanding our intellectual property portfolio is a key part of our strategy,” said John Erb, Chief Executive Officer of Nuwellis. “Each new patent reinforces our commitment to building long-term ...

Opinion: Fish attorneys say that changes at the US Patent and Trademark Office and broader regulatory moves could increase ...

Cyber A.I. Group, Inc. (“CyberAI” or the “Company”), an emerging growth Cybersecurity, Artificial Intelligence and IT services company engaged in the development of next-generation AI-driven ...

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension This patent covers novel cyclic peptides and their use in treating solid tumor ...